ArticleRevista panamericana de salud publica = Pan American journal of public health2020
[Costs attributable to obesity, hypertension, and diabetes in the Unified Health System, Brazil, 2018Costos atribuibles a la obesidad, la hipertensión y la diabetes en el Sistema Único de Salud de Brasil, 2018].
Article in Revista panamericana de salud publica = Pan American journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 183 citations in OpenAlex.
- Content Analysis of Brazilian Mobile Applications Targeting Blood Pressure Management: A Systematic Search.Arquivos brasileiros de cardiologia · 2025Pooled it
- Obesity and Associated Factors in Brazilian Adults: Systematic Review and Meta-Analysis of Representative Studies.International journal of environmental research and public health · 2024Pooled it
- A Hybrid Lifestyle Program and Metabolic Health in Adults With Obesity: The PRAMEV Randomized Clinical Trial.JAMA network open · 2026Trial
- Trial
- The Effects of Functional Training on the Ambulatory Blood Pressure and Physical Fitness of Resistant Hypertensive Elderly People: A Randomized Clinical Rehearsal with Preliminary Results.International journal of environmental research and public health · 2024Trial
- Impact of a low-carbohydrate diet on cardiometabolic parameters in individuals with and without diabetes: An 8-year longitudinal study within the ELSA-Brasil cohort.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026Article
- Challenges for Implementing Integrated Obesity Management in Municipal Health Plans of Mato Grosso do Sul (Brazil): A Qualitative Study.Health science reports · 2026Article
- Telenutrition promoting equity of access in the SUS: a descriptive study.Sao Paulo medical journal = Revista paulista de medicina · 2026Article
- Occurrence of metabolic syndrome in young adults and inequalities according to sex, skin color, and socioeconomic status: evidence from two birth cohorts in Southern Brazil.Cadernos de saude publica · 2026Article
- Ultra-processed food consumption and body mass index from adolescence to early adulthood: multi-trajectory analysis using data from the 1993 Pelotas (Brazil) birth cohort.Cadernos de saude publica · 2026Article
- Characterization of Novel Angiotensin-Converting Enzyme Inhibitory Peptides.ACS medicinal chemistry letters · 2025Article
- Household Food Insecurity and Feeding Practices in Brazilian Children < 5 Years: Results From Brazilian National Survey on Child Nutrition.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025Article
- Exploring the potential relationship between serum biomarkers in obese individuals and cancer using FTIR, metabolomics, and lipidomics.Metabolomics : Official journal of the Metabolomic Society · 2025Article
- Herbal Medicines for Weight Loss and Lipid Profile Improvement: A Scoping Review of Therapeutic Effects and Safety.Phytotherapy research : PTR · 2025Article
- Population characteristics, prescription patterns and glycemic control of users of flash glucose monitoring systems in Brazil: a real-world evidence study.Diabetology & metabolic syndrome · 2025Article
- Comparison of scenarios in the trajectory of body mass index among adolescents monitored in primary health care: the VigiNUTRI Brazil study.Scientific reports · 2025Article
- Cardiovascular risk and statin prescription in primary care: an observational study, São Leopoldo, 2018-2021.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2025Observational
- Nurses' perspectives on the use of telemonitoring in the management of people with diabetes and hypertension.Revista brasileira de enfermagem · 2025Article
- Article
- Steatosarcopenia: A New Terminology for Clinical Conditions Related to Body Composition Classification.Life (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the cost attributable to arterial hypertension, diabetes and obesity in the Unified Health System of Brazil in 2018.
methodThe study estimated the cost attributable to non-communicable chronic diseases based on relative risk and population prevalence of hypertension, diabetes, and obesity, considering the cost of hospitalizations, outpatient procedures, and medications distributed by the SUS to treat these diseases. Cost data were obtained from SUS information systems. The analysis explored the cost of disease according to sex and age in the adult populatio
resultsThe total cost of hypertension, diabetes, and obesity in the SUS reached R$ 3.45 billion (95%CI: 3.15-3.75) in 2018, that is, more than US$ 890 million. Of this amount, 59% referred to the treatment of hypertension, 30% to diabetes, and 11% to obesity. The age group from 30 to 69 years accounted for 72% of the total costs, and women accounted for 56%. When obesity was considered separately as a risk factor for hypertension and diabetes, the cost attributable to this diseases reached R$ 1.42 billion (95%CI: 0.98-1.87), i.e., 41% of the total cost.
conclusionsThe estimates of costs attributable to the main chronic diseases associated with inadequate diet revealed a heavy economic burden of these disorders for the SUS. The data show the need to prioritize integrated and intersectoral policies for the prevention and control of hypertension, diabetes, and obesity, and may support the advocacy for interventions such as fiscal and regulatory measures to ensure that the objectives of the United Nations Decade of Action on Nutrition are met.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.